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ABSTRACT 
 
Background: Clinical ultrasound (US) uses ultrasonic scattering contrast to characterize subcutaneous anatomic 
structures. Photoacoustic (PA) imaging detects the functional properties of thick biological tissue with high optical 
contrast. In the case of image-guided cancer ablation therapy, simultaneous US and PA imaging can be useful for 
intraoperative assessment of tumor boundaries and ablation margins. In this regard, accurate co-registration between 
imaging modalities and high sensitivity to cancer cells are important.  
 
Methods: We synthesized poly-lactic-co-glycolic acid (PLGA) microbubbles (MBs) and nanobubbles (NBs) 
encapsulating India ink or indocyanine green (ICG). Multiple tumor simulators were fabricated by entrapping ink MBs 
or NBs at various concentrations in gelatin phantoms for simultaneous US and PA imaging. MBs and NBs were also 
conjugated with CC49 antibody to target TAG-72, a human glycoprotein complex expressed in many epithelial-derived 
cancers. 
 
Results:  Accurate co-registration and intensity correlation were observed in US and PA images of MB and NB tumor 
simulators.  MBs and NBs conjugating with CC49 effectively bound with over-expressed TAG-72 in LS174T colon 
cancer cell cultures. ICG was also encapsulated in MBs and NBs for the potential to integrate US, PA, and fluorescence 
imaging.  
 
Conclusions:  Multifunctional MBs and NBs can be potentially used as a general contrast agent for multimodal 
intraoperative imaging of tumor boundaries and therapeutic margins.  
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1. INTRODUCTION 
 
Thermal ablation processes destroy tumor tissue by localized deposition of thermal energy that causes protein 
denaturation and coagulation necrosis [1]. They hold the promise of less invasive cancer management with minimal 
trauma, outpatient treatment, and fast recovery. However, broad clinical acceptance of many cancer ablation processes is 
hindered by controversial issues and concerns related with clinical safety, efficacy, and long-term local recurrence. One 
major limitation is the lack of intraoperative assessment of tumor boundaries and ablation margins [2]. Clinical ultrasound 
(US) has been used for tumor localization and ablation probe placement in a cancer ablation procedure [3]. However, US 
alone is not appropriate for intraoperative imaging because of its low specificity for soft tissue mass and its susceptibility 
to ablation-induced gas bubbles. In this regard, photoacoustic (PA) imaging may provide complementary information 
regarding tumor functional characteristics and ablation margins. Integrating US and PA into a single handheld imager 
will take advantages of both modalities without introducing too much hardware complexity. However, accurate 
calibration and co-registration between these two modalities is difficult because of the mismatch between tissue 
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structural and functional heterogeneities. A dual-mode imaging agent with simultaneously strong US and PA contrasts 
will not only help to calibrate the US-PA hybrid imaging system but also provide imaging markers for tumor boundary 
and therapeutic margin assessment with multiple imaging modalities. This paper describes our recent effort to 
encapsulate India ink in biodegradable microbubbles (MBs) and nanobubbles (NBs) for concurrent US and PA imaging.  
 
2. FABRICATING DUAL-MODE MBS AND NBS 
 
PLGA (50:50, RG 502H 12000 Da MW, Boehringer Ingelheim) MBs and NBs encapsulating India ink were fabricated 
with a modified double emulsion process[4]. Firstly, four solutions were prepared: (1) 5 mL of 2.5% w/v PLGA solution 
of methylene chloride (CH2Cl2, Fisher Scientific), (2) 50 mL of 4% w/v polyvinyl alcohol (PVA, Fisher Scientific) 
aqueous solution, (3) 0.5 mL of 50% v/v ink (Higgins Fountain Pen India non-waterproof black ink, Sanford) and  4% 
w/v PVA aqueous solution, and (4) 100 mL of 5% v/v isopropanol aqueous solution. Secondly, the 0.5 mL aqueous 
solution of ink and PVA was added to the 5 mL PLGA solution of CH2Cl2, and emulsified in an ice bath. Then, the 
emulsion was added drop-wise with a 1000 μL pipette to the 50 mL PVA solution in an ice bath and emulsified again. 
The double emulsion was then added to the isopropanol solution, stirred for 1.5 hours by a magnetic stirrer, and then 
centrifuged. After centrifugation, the supernatant was discarded, and the bubble precipitate was washed by deionized 
water. The process of centrifugation and washing was repeated three times. The washed spheres were then freeze-dried 
by a Lyph-lock 4.5 freeze dry system (Labcono Corp.) for 36 hours. Dried bubbles were harvested and stored in a glass 
bottle at 0 °C for further use. For the MBs, the first and second emulsion steps were conducted with a model 17105 
Omni Mixer homogenizer (Omini International) at 20,000 rpm for 5 minutes and 10,000 rpm for 3 minutes, respectively. 
The centrifugation was carried out with a Centrifuge 5810R (Eppendorf) at 1500 rpm for 10 minutes. For the NBs, the 
first and the second emulsion steps were conducted with an Omni-Ruptor 250 ultrasound probe (Omini International) at 
90 W for 2 minutes and at 30 W for one minute, respectively. The centrifugation was carried out with a SORVALL RC-
5B high speed centrifuge at 9000 rpm for 10 minutes.  Figure 1(a) shows the cross-section of a MB or NB. The solid 
PLGA shell encapsulates india ink and air inside, forming a stable spherical bubble. The average size of MBs is 1.01 ± 
0.73 μm, and that of NBs is 0.29 ± 0.09 µm. To fabricate dual-mode tissue simulating phantoms, we first mixed gelatin 
powder (Great Lakes Gelatin, grayslake, IL) with warm water (~45˚C). The mixture was then degassed, forming 
0.15mg/mL clear gelatin solution. Eight cylindrical tumor simulators were fabricated by dispersing four concentrations 
(2.5, 5, 10, 15 mg/mL) of MBs or NBs respectively into above clear gelatin solution. The tumor simulators were cast into 
a gelatin pad (3 cm × 4 cm × 0.5 cm).  
 
2. DUAL MODE US AND PA IMAGING 
 
The tissue simulating phantom was imaged by a PA macroscope and a 5MHz US probe. For PA imaging, the mechanism 
of the ring-shaped light illumination is described fully in reference [5]. The schematic of the system is showed in Figure 
1. To irradiate the phantoms, we used the wavelength-tunable Ti-Sapphire laser (LT-2211A, LOTIS TII), pumped by a 
Q-switched Nd:YAG laser (LS-2137, LOTIS) with a pulse duration of 6.5 ns and a pulse repetition rate of 10 Hz. The 
light fluence on the phantom surface was 3.4 mJ/cm2, within the current ANSI limit [6]. A donut-shaped light (λ = 767 
nm), formed by concave and conical lenses, traveled through an optical condenser, and was coaxially focused with the 
ultrasound focal zone in water. The phantoms were positioned under a water tank that had a window with a transparent 
thin membrane. The PA waves, detected by a single-element 5-MHz ultrasound transducer (V308, Panametrics-NDT), 
were first amplified and then transferred to an oscilloscope. The axial and lateral resolutions were 138 and 490 µm, 
respectively. One-dimensional depth-sensitive images along the z-axis (referred to as A-lines) were obtained by 
measuring the times of arrival of the PA signals. By scanning the samples along the x and y directions, three-dimensional 
PA images were formed. Three-dimensional images were projected into two-dimensional images through maximum 
amplitude projection (MAP), which projected the strongest signal along each A-line onto the corresponding x-y plane. 
For US imaging, the phantom is bathed in cool water and US signal is acquired from the side. Beam focus is set to 
~1.6cm which is about half the traveling distance of US wave through the phantom. Time gain control (TGC) is default 
to provide comparable contrast for each imaging slide. 
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Figure 1. Schematic of the photoacoustic macroscope 
 
Figures 2(a) to 2(c) show the photographic, PA, and US images acquired from a tissue simulating phantom as described 
above. The tissue simulating phantom embedded 8 tumor simulators with different MB and NB concentrations. Tumor 
simulators #1 to #4 dispersed MBs at concentration levels of 2.5, 5, 10, 15 mg/mL, respectively. Tumor simulators #5 to 
#8 dispersed NBs at concentration levels of 2.5, 5, 10, 15 mg/mL, respectively. Figure 2(d) shows the correlation 
between the PA signal strength and the MB/NB concentration. Figure 2(c) shows the correlation between the US contrast 
and the MB/NB concentration. Both MBs and NBs show PA and US contrasts. 2.5 and 5.0 mg/mL MBs are not quite 
clearly visualized in US image, the rest of the tumor simulators can be clearly discerned. The NBs seem to be better 
visible than MBs in US. While the mechanism for acoustic contrast enhancement by MBs has been reviewed in [7], the 
mechanism for NBs is still not quite clear. A possible explanation is the aggregation and layering effect of NBs [7-9]. The 
above results show that by encapsulating India ink into MBs or NBs, it is possible to provide dual-mode contrast for PA 
and US imaging. 
 
 
 
Figure 2. a) A photo of the tissue simulating phantom; (b) PAT image of the phantom; (c) US image of the phantom; The number 1 
through 4 correspond to 2.5, 5, 10, 15 mg/mL MBs and 5 through 8 correspond to 2.5, 5, 10, 15 mg/mL NBs; (d) quantitative 
comparison of PAT signal; (e) quantitative comparison of US signal. 
 
We added chicken breast tissues atop the phantom to increase imaging depth. With a 1-cm thick layer of chicken breast 
tissue, all eight targets are clearly shown in Figure 3. 
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Figure 3. PAT image of the phantom positioned below 1 cm of chicken breast tissues. 
 
 
3. CONJUGATING MBS AND NBS FOR CANCER TARGETING 
 
TAG-72 is a human glycoprotein complex expressed in many epithelial-derived cancers, including colorectal, pancreatic, 
breast, ovarian, and gastric cancers [10]. Anti-TAG-72 antibodies, such as murine B72.3, murine CC49, and humanized 
HuCC49ΔCH2, have been used to target over-expressed TAG-72 in both cancer xenograft models and tissue samples 
from cancer patients [11, 12]. In the past, we have conjugated murine CC49 and HuCC49ΔCH2 with Cy7, an ICG 
derivative, for near infrared fluorescence imaging on LS174T colorectal cancer xenograft nude mice [13].  Our animal 
experiments demonstrated that Cy7 labelled CC49 and HuCC49ΔCH2 are able to target tumors in living colorectal cancer 
xenograft mice for near infrared fluorescence imaging of tumor boundaries. We also conjugated HuCC49ΔCH2 antibody 
with MBs and NBs for cancer targeting and imaging [14].  Our binding tests on LS174T cancer cell culture showed that 
antibody conjugated MBs and NBs can effectively bind with cancer cells, while bare MBs and NBs do not bind with 
cancer cell well.  
 
4. CONCLUSION AND FUTURE WORK 
 
We have successfully demonstrated the dual-mode contrasts of MBs and NBs encapsulating India ink. By conjugating 
MBs and NBs with cancer-targeting antibodies and by encapsulating India ink, we may produce novel contrast agents for 
simultaneous US and PA imaging of tumor boundaries as well as ablation margins. It is also possible to encapsulate 
many other imaging agents into MBs and NBs for multimodal imaging. For example, Gadolinium can be encapsulated 
for Magnetic Resonance Imaging. MBs and NBs can be radiolabelled for PET-CT imaging. We expect that such 
multimodal MB and NB agents will provide disease-specific contrasts for intraoperative tumor assessment. 
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